| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 6,874 | 7,513 | 7,748 | | Cost of Revenue | 5,314 | 5,544 | 5,223 | | | Gross Profit | 1,560 | 1,969 | 2,525 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 6,065 | 5,341 | 4,092 | | Non Recurring | 631 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (4,505) | (3,372) | (1,567) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| 1 | | Earnings Before Interest And Taxes | (4,699) | (3,372) | (1,566) | | Interest Expense | 194 | 37 |
-
| | Income Before Tax | (4,699) | (3,409) | (1,566) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,699) | (3,409) | (1,566) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (4,699) | (3,409) | (1,566) | | Preferred Stock And Other Adjustments |
-
| (54) | (295) | | | Net Income Applicable To Common Shares | ($4,699) | ($3,463) | ($1,861) |
|
0.16% Nasdaq 
Income Statement
